Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by Duedilligence10on Jan 04, 2021 7:53pm
163 Views
Post# 32220952

RE:RE:RE:St Peter, SPECIAL request.

RE:RE:RE:St Peter, SPECIAL request.

Who knows.  $10 might is not far fetched.  There is a fortune to be made in fight against Covid.  Another venture stock with a rapid Covid test had a huge volume and good sp uptick today.  About a week or so ago there was another venture company in the fight against Covid that also had huge numbers.  Covid is getting worse and is a worldwide problem, the vaccines are rolling out slow and are unstable.  Clearly investors are looking for anti-Covid companies.  Many  are  weary of crypto$, weed, retail, transportation and other risky business.  At this point in time VXL and similar companies appear to be in the sweet spot.  Right now, you can't argue with the numbers.  

<< Previous
Bullboard Posts
Next >>